0 NYSE Companies - July 2, 2024Renasant Announces Sale of Renasant Insurance to Sunstar Insurance GroupTUPELO, Miss., July 02, 2024 (GLOBE NEWSWIRE) — Renasant Corporation (NYSE: RNST) announced today that it has sold the assets […]Read More
0 NASDAQ Companies - July 2, 2024Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross ProceedsREHOVOT, Israel, July 02, 2024 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage […]Read More
0 NASDAQ Companies - July 2, 2024Kratos Valkyrie Demonstrates Affordable Runway Flexibility with Recent Take-Off and Flight OperationsSAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, […]Read More
0 NASDAQ Companies - July 2, 2024Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report– Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. – Conducted first stakeholder assessment […]Read More
0 TSX Venture News - July 2, 2024Abacus Announces Closing of the Willow Porphyry Copper Property and Amends Certain Terms of the Acquisition AgreementVANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — Abacus Mining & Exploration Corporation (“Abacus” or “The Company”) (TSXV:AME) announces […]Read More
0 NASDAQ Companies - July 2, 2024American Airlines releases 2023 Sustainability ReportFORT WORTH, Texas, July 02, 2024 (GLOBE NEWSWIRE) — American Airlines released its 2023 Sustainability Report today, documenting its work […]Read More
0 NYSE Companies - July 2, 2024Toll Brothers Announces Luxury Riverfront Townhome Community Coming Soon to Jacksonville, FloridaJACKSONVILLE, Fla., July 02, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced […]Read More
0 Canadian Stock Exchange News - July 2, 2024Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent ExposureTORONTO, July 02, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a […]Read More